FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

769520004: Product containing precisely rotigotine 166.667 microgram/1 hour prolonged-release transdermal patch (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3695477011 Rotigotine 166.667 microgram/hour prolonged-release transdermal patch en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3695478018 Product containing precisely rotigotine 166.667 microgram/1 hour prolonged-release transdermal patch (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Rotigotine (substance) true Inferred relationship Some 1
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch Count of base of active ingredient un false Inferred relationship Some
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch Has manufactured dose form Prolonged-release transdermal patch (dose form) true Inferred relationship Some
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch This attribute specifies the numerator unit for the concentration strength of a product. mcg true Inferred relationship Some 1
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch Is a Rotigotine-containing product in transdermal dose form false Inferred relationship Some
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value un false Inferred relationship Some 1
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Rotigotine (substance) true Inferred relationship Some 1
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch This attribute specifies the denominator unit for the concentration strength of a product. hour true Inferred relationship Some 1
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch Has concentration strength numerator value 166.667 false Inferred relationship Some 1
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch Is a Product containing only rotigotine in transdermal dose form (medicinal product form) true Inferred relationship Some
Rotigotine 166.667 microgram/hour prolonged-release transdermal patch Plays role Antiparkinson therapeutic role false Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start